Cargando…
Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750104/ http://dx.doi.org/10.1007/s40278-020-87803-x |
Ejemplares similares
-
Lopinavir/ritonavir/tocilizumab: Hypertriglyceridaemia following off-label use: 2 case reports
Publicado: (2020) -
Lopinavir/ritonavir: Hepatobiliary disorder and hypertriglyceridaemia following off label use: case report
Publicado: (2021) -
Multiple drugs: Acute pancreatitis, hypertriglyceridaemia and off-label use in coronavirus disease 2019: 2 case reports
Publicado: (2020) -
Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19
por: Nakamura, Hideta, et al.
Publicado: (2020) -
Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)